Myocardial dysfunction in hypertrophic cardiomyopathy.

Myocardial dysfunction in hypertrophic cardiomyopathy.

Bibliographic Details
Main Authors:	Ashrafian, H, Watkins, H
Format:	Journal article
Language:	English
Published:	2001

Similar Items

Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.
by: Ashrafian, H, et al.
Published: (2003)

Exercise-induced ventricular dysfunction in hypertrophic cardiomyopathy: stunning by any other name?
by: Ashrafian, H, et al.
Published: (2008)

Metabolic perturbations in the pathogenesis of hypertrophic cardiomyopathy
by: Ashrafian, H, et al.
Published: (2005)

The genetics of hypertrophic cardiomyopathy: Teare redux.
by: Watkins, H, et al.
Published: (2008)

Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy.
by: Ashrafian, H, et al.
Published: (2011)

Correlates of myocardial fibrosis in hypertrophic cardiomyopathy
by: Kramer, CM, et al.
Published: (2018)

Sudden death in hypertrophic cardiomyopathy.
by: Watkins, H
Published: (2000)

A change in myocardial deformity as an early marker for myocardial dysfunction in children with hypertrophic cardiomyopathy
by: N. Yu. Chernykh, et al.
Published: (2016-11-01)

Microvascular Dysfunction in Hypertrophic Cardiomyopathy
by: Francesco Pelliccia, et al.
Published: (2022-11-01)

Identification of myocardial disarray in patients with hypertrophic cardiomyopathy and ventricular arrhythmias
by: Ariga, R, et al.
Published: (2019)

Diffusion tensor magnetic resonance imaging of myocardial disarray in hypertrophic cardiomyopathy
by: Ariga, R, et al.
Published: (2018)

Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications
by: Raman, B, et al.
Published: (2018)

METABOLIC ALTERATION IN HYPERTROPHIC CARDIOMYOPATHY (METAL-HCM STUDY): RANDOMISED DOUBLE BLINDED PLACEBO CONTROLLED TRIAL OF PERHEXILINE THERAPY IN PATIENT WITH HYPERTROPHIC CARDIOMYOPATHY
by: Abozguia, K, et al.
Published: (2010)

Evaluation of diastolic dysfunction in children with hypertrophic cardiomyopathy and its relationship with development of myocardial fibrosis
by: Salem Elsayed Deraz, et al.
Published: (2023-06-01)

Non-invasive imaging of myocardial disarray associates with ventricular arrhythmia in hypertrophic cardiomyopathy
by: Ariga, R, et al.
Published: (2017)

Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: New insights from multiparametric MRI
by: Petersen, S, et al.
Published: (2007)

Regression of dilated-hypokinetic hypertrophic cardiomyopathy by biventricular cardiac pacing.
by: Ashrafian, H, et al.
Published: (2007)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
by: Hudsmith, L, et al.
Published: (2006)

Myocardial fibrosis in desmin-related hypertrophic cardiomyopathy
by: Dai Qinyi, et al.
Published: (2010-11-01)

Metabolomics in hypertrophic cardiomyopathy and other myocardial diseases
by: Pal, N
Published: (2015)

HYPERTROPHIC CARDIOMYOPATHY AND MYOCARDIAL CRYPT OF THE LEFT VENTRICLE
by: Yu. V. Frolova, et al.
Published: (2017-02-01)

Genetic clues to disease pathways in hypertrophic and dilated cardiomyopathies.
by: Watkins, H
Published: (2003)

Blunted myocardial oxygenation response during vasodilator stress in patients with hypertrophic cardiomyopathy.
by: Karamitsos, T, et al.
Published: (2013)

Linked genetic modifiers in hypertrophic cardiomyopathy
by: Ektisham, J, et al.
Published: (2004)

Hypertrophic cardiomyopathy: from molecular and genetic mechanisms to clinical management
by: Watkins, H
Published: (2001)

Assigning a causal role to genetic variants in hypertrophic cardiomyopathy.
by: Watkins, H
Published: (2013)

Mechanisms and prognostic impact of myocardial ischaemia in hypertrophic cardiomyopathy
by: Coleman, JA, et al.
Published: (2023)

Hypertrophic Cardiomyopathy versus Storage Diseases with Myocardial Involvement
by: Anna Burban, et al.
Published: (2023-08-01)

Genetic Dissection of Hypertrophic Cardiomyopathy with Myocardial RNA-Seq
by: Jun Gao, et al.
Published: (2020-04-01)

Myocardial Fibrosis in the Pathogenesis, Diagnosis, and Treatment of Hypertrophic Cardiomyopathy
by: Zeyi Cheng, et al.
Published: (2021-04-01)

MYOCARDIAL REMODELLING TYPES IN HYPERTROPHIC NON-OBSTRUCTIVE CARDIOMYOPATHY
by: D. V. Bogdanov
Published: (2015-05-01)

The prognostic impact of septal myectomy in obstructive hypertrophic cardiomyopathy.
by: Watkins, H, et al.
Published: (2005)

Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging.
by: Petersen, SE, et al.
Published: (2007)

Ascertainment strategies and genotype:phenotype correlations in hypertrophic cardiomyopathy.
by: Blair, E, et al.
Published: (2003)

Pathogenic Mechanisms of Hypertrophic Cardiomyopathy beyond Sarcomere Dysfunction
by: Chun Chou, et al.
Published: (2021-08-01)

Microvascular Dysfunction Is Associated With Impaired Myocardial Work in Obstructive and Nonobstructive Hypertrophic Cardiomyopathy: A Multimodality Study
by: Pedro Garcia Brás, et al.
Published: (2023-04-01)

Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy.
by: Dass, S, et al.
Published: (2012)

Myocardial bridging in obstructive hypertrophic cardiomyopathy: a risk factor for myocardial fibrosis
by: Changpeng Song, et al.
Published: (2024-02-01)

Differentiation of Myocardial Properties in Physiological Athletic Cardiac Remodeling and Mild Hypertrophic Cardiomyopathy
by: Lars G. Klaeboe, et al.
Published: (2024-02-01)

Radiomics and deep learning for myocardial scar screening in hypertrophic cardiomyopathy
by: Ahmed S. Fahmy, et al.
Published: (2022-06-01)